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 Introduction 
 The orexins/hypocretins represent a novel family of 
neuropeptides which were independently identiﬁ ed by 
two groups  [1, 2] . De Lecea et al.  [1] described a hypo-
thalamus-speciﬁ c mRNA that encodes preprohypocretin, 
which was thought to be the precursor of two neuropep-
tides, namely hypocretin-1 and -2. At about the same time, 
Sakurai et al.  [2]  identiﬁ ed two neuropeptides that acti-
vate two closely related orphan G-protein-coupled recep-
tors. These were named orexins after the Greek word for 
appetite, because these peptides stimulated food intake. 
The proteolytic cleavage of a precursor releases two pep-
tides, orexin A and orexin B, which share 46% sequence 
identity  [3] . It is now accepted that the terms orexin and 
hypocretin represent identical molecular entities  [3] . 
 Anatomical studies in rodents have determined the 
hypothalamus as the main localization of these peptides, 
where they are expressed in the lateral hypothalamic area, 
fornix and posterior hypothalamus  [4–9] . In rodents, 
orexin-A- and -B-containing neurons project widely into 
the olfactory bulb, cerebral cortex, thalamus, and brain-
stem  [4, 9] . 
 There are less data dealing with the distribution of 
orexins in the human brain  [10, 11] . The highest concen-
tration of orexin A has been found in the human hypo-
thalamus, followed by the thalamus, medulla oblongata, 
and pons  [10] . Orexin-containing neurons localized to the 
 Key Words 
 Human retina · Hypocretin · Ocular vessels · Orexins · 
Receptors · Retina
 Abstract 
 Objectives: Orexins A and B are neuropeptides involved 
in the regulation of feeding behavior, energy homeosta-
sis and arousal. In the human retina, however, immuno-
histochemical localization of orexins and their receptors, 
OX-R1 and OX-R2, has not been ascertained.  Methods: 
We localized orexins A and B, OX-R1 and OX-R2 in the hu-
man retina using immunohistochemistry. Retinae from 2 
Alzheimer’s disease (AD) patients provided preliminary 
evidence for possible orexin alterations.  Results:  Orexin 
A, orexin B and OX-R1 were localized in ganglion and 
amacrine cells, cellular processes in the inner and outer 
plexiform layer and in the inner segments of photore-
ceptor cells. There was no OX-R2 immunoreactivity in 
the retina. The staining intensity for both orexins was 
decreased in the AD patients.  Conclusion:  This immuno-
histochemical study provides the fi rst evidence for the 
distribution of orexin A, orexin B and OX-R1 in the hu-
man retina. The localization pattern suggests a modula-
tory role for orexins in the interactions of those retinal 
cells which transmit light information to the suprachi-
asmatic nuclei, and thus may be involved in circadian 
rhythm entrainment. 
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perifornical region of the human posterior hypothalamus 
innervate all areas of the cerebral cortex, hypothalamus, 
locus ceruleus, raphe nuclei, midline thalamus and fore-
brain  [11] . In human peripheral tissues, orexin A expres-
sion has been detected in ganglion cells of the thoracic 
sympathetic trunk and myenteric plexus, endocrine cells 
of the gastrointestinal tract and islet cells of the pancreas 
 [12] . The unique neuronal distribution and innervation 
pattern of orexin neurons suggest complex roles of these 
peptides in autonomic and neuroendocrine control, in-
cluding the regulation of feeding behavior and energy ho-
meostasis  [9] , as well as arousal  [11] . 
 Orexins are considered to exert their functions through 
two speciﬁ c orexin receptors, OX-R1 and OX-R2, both 
having a seven transmembrane domain topology, gener-
ated from two separate genes  [2] . Orexin A has a high af-
ﬁ nity to both receptors, whereas orexin B shows a 10-fold 
higher afﬁ nity to OX-R2 than to OX-R1. The distribu-
tion of both receptors has been determined in rats  [13–
18] , where high levels of OX-R1 mRNA were detected in 
the ventromedial hypothalamic nucleus, thalamic nuclei, 
cerebral cortex, basal ganglia, tenia tecta, hippocampus, 
dorsal raphe and locus ceruleus  [13, 15, 16] . OX-R2, on 
the other hand, was mainly expressed in the paraventric-
ular nucleus, cerebral cortex, nucleus accumbens, sub-
thalamic and paraventricular thalamic nuclei, and an-
terior pretectal nucleus  [16, 17] . These ﬁ ndings support 
the hypothesis that orexins may have important actions 
not only on hypothalamic neurons controlling food intake 
and ﬂ uid balance, but also on different neuronal systems. 
Orexin receptor distribution has not yet been investigated 
in the human brain. 
 Orexins are directly involved in the regulation of sleep. 
Narcolepsy, a neurological disorder characterized by hy-
persomnia and catalepsy, is associated with orexin loss 
or rarely with orexin receptor gene mutations  [19–21] . 
Orexins may be implicated in the circadian regulation of 
sleep propensity, given the presence of OX-R1 in the su-
prachiasmatic hypothalamic nuclei (SCN)  [15] . Light in-
formation transduced to the SCN via the retina is neces-
sary to entrain circadian rhythms  [22–24] , and the retina 
itself contains a circadian pacemaker  [25] . Therefore, we 
investigated the distribution of orexin A, orexin B and 
their receptors in the retina using immunohistochemis-
try. Retina samples of 2 patients with Alzheimer’s disease 
(AD) were also investigated, since AD, a neurodegenera-
tive disorder characterized by cognitive decline, is often 
accompanied by circadian rhythm disturbances and SCN 
degeneration  [26] . 
 Patients and Methods 
 Human Tissue 
 Eyes of 9 elderly control subjects without neurological or psy-
chiatric disease (7 women and 2 men, mean postmortem delay
23 h 57 min) and 2 male AD cases (mean postmortem delay 16 h 
15 min) were investigated ( table 1 ). The diagnosis of AD was made 
on clinical evaluation and conﬁ rmed by postmortem neuropatho-
logical examination. The cause of death was heart failure in most 
cases, pancreatitis in 1 case and pneumonia in 2 cases ( table 1 ). 
Sample collection was according to ethics committee criteria and 
the Declaration of Helsinki in 1975. The parafﬁ n-embedded tissues 
were ﬁ xed in 4% paraformaldehyde and cut sagittally in 4- Ì m-thick 
consecutive sections. 
 Immunohistochemistry 
 Immunohistochemical detection of all antigens was done by 
peroxidase staining using the peroxidase substrate 3-amino-9-eth-
ylcarbazole. The method has been reported in detail previously 
 [24, 27] . Adjacent sections were incubated with antisera or pri-
mary antibodies against orexin A (rabbit anti-orexin-A serum, 
Peninsula Laboratories, San Carlos, Calif., USA), orexin B (rabbit 
anti-orexin-B serum, Peninsula Laboratories), OX-R1 (rabbit poly-
clonal antibody, Chemicon International, Temecula, Calif., USA), 
or OX-R2 (rabbit polyclonal antibody, Chemicon International). 
According to the company, the antisera against orexin A and orexin 
B show a 100% cross-reactivity with orexin A and B, respectively. 
The afﬁ nity-puriﬁ ed antibody against OX-R1 recognizes a 16-ami-
no-acid sequence near the C-terminus of human OX-R1 and the 
antibody against OX-R2 was developed against a 19-amino-acid 
peptide near the N-terminus of human OX-R2  [1, 2] . The opti-
mum concentration for all antisera and antibodies was experimen-
tally determined to be 1:200. To test the speciﬁ city of the antisera 
and the antibodies, control samples were stained simultaneously 
following the same procedure as the test samples but omitting the 
antisera or the primary antibodies. After the peroxidase reaction 
with ACE, the samples were counterstained with Mayer’s hemalum 
Table 1. Data of controls and AD patients
No. Age
years
Gender Postmortem
delay
Cause of 
death
Controls
1 85 m 31 h heart failure
2 97 f 26 h heart failure
3 91 f 24 h heart failure
4 69 f 20 h pancreatitis
5 76 f 9 h 40 min heart failure
6 88 f 31 h heart failure
7 76 f 9 h pneumonia
8 92 m 24 h 32 min heart failure
9 85 f 6 h 33 min heart failure
AD patients
1 83 m 15 h heart failure
2 84 m 17 h 30 min pneumonia
pat662.indd   212 15.07.2004   17:49:56
D
ow
nl
oa
de
d 
by
: 
Un
ive
rs
itä
t Z
ür
ich
,  
Ze
nt
ra
lb
ib
lio
th
ek
 Z
ür
ich
   
   
   
 
13
0.
60
.4
7.
22
 - 
7/
7/
20
16
 3
:2
9:
00
 P
M
 Orexins in the Human Retina  Pathobiology 2004;71:211–216 213
to mark the cell nuclei. All sections were assessed for localization 
and intensity of speciﬁ c immunoreactivities on a semiquantitative 
scale by two blinded observers. 
 Results 
 We observed orexin-A-, orexin-B- and OX-R1-immu-
noreactive structures in the human retina ( table 2 ). No 
ocular vessels, including central, retinal and choroidal ar-
teries and veins, stained for any of the investigated an-
tigens. 
 Different cells and cellular processes within the retina 
revealed an intense immunoreaction for orexin A, orex-
in B and OX-R1  (ﬁ g. 1 A–C,  ﬁ g. 2 A, B), whereas OX-R2 
immunoreactivity was entirely missing  (ﬁ g. 1 D,  table 2 ). 
Control adjacent sections omitting the primary antibody 
were not immunoreactive for any of the tested antigens, 
conﬁ rming the speciﬁ city of the immunoreaction  (ﬁ g. 1 E). 
Starting at the inner layers of the retina, the ganglion cells 
within the ganglion cell layer were the most prominent 
cellular structures which intensively stained for orexin A, 
orexin B or OX-R1  (ﬁ g. 1 A–C). The immunoreaction ac-
cumulated in a perinuclear pattern in the ganglion cell so-
mata and in the primary cellular processes. The ganglion 
cell processes within the nerve ﬁ ber layer were also posi-
tive for the observed antigens. Adjacent to the ganglion 
cell layer, cell processes within the inner plexiform layer 
were also positive for all three antigens  (ﬁ g. 1 A–C). The 
inner nuclear layer revealed single orexin-A-, orexin-B- or 
OX-R1-immunoreactive cells ( ﬁ g. 1 A–C). According to 
their cellular structure, these cells could be identiﬁ ed as 
amacrine cells. The outer plexiform layer also contains 
orexin-A-, orexin-B- or OX-R1-immunoreactive cell pro-
cesses both in the central and mid-peripheral parts of the 
retina  (ﬁ g. 1 A–C). The inner segments of the photore-
ceptor cells, located adjacent to the outer nuclear layer 
containing the somata of the photoreceptor cells, stained 
for all three antigens  (ﬁ g. 2 A, B). Finally, the Henle layer, 
interposed between the inner and outer nuclear layer, also 
contained immunolabeling for all antigens except OX-
R2  (ﬁ g. 1 A–C). The 9 control cases in the present study 
showed individual differences in the staining intensity 
for the observed antigens ( table 2 ). Interestingly, even 
those with the weakest staining for orexin A or orexin B 
still revealed very intense OX-R1 staining ( table 2 , case 
No. 2 and No. 4). 
 In the 2 AD cases, the retina displayed similar cel-
lular distribution patterns for orexin A  (ﬁ g. 1 F), orexin 
B or OX-R1 immunoreactivity as for controls, and was 
also devoid of OX-R2 immunoreactivity. Ganglion cells, 
amacrine cells, and cell processes within the inner and 
outer plexiform layer were positive for all three antigens. 
The only difference was the obvious decrease in staining 
Table 2. Semiquantitative data tabulating the intensity of immunoreactivity of orexin A, orexin B, and orexin 
receptors OX-R1 and OX-R2 in the retina of controls and AD patients
No. Orexin A Orexin B OX-R1 OX-R2
GC, AC, PC, IOPL GC, AC, PC, IOPL GC, AC, PC, IOPL GC, AC, PC, IOPL
Controls
1 +++, ++, +++, ++ +++, ++, ++, ++ +++, ++, +++, ++ –
2 ++, +, +, + ++, +, ++, + +++, ++, ++, ++ –
3 +, ++, ++, ++ ++, ++, ++, + +++, ++, +++, ++ –
4 ++, +, ++, – ++, +, –, – +++, ++, +++, ++ –
5 +++, +++, ++, ++ +++, ++, +++, ++ +++, ++, +++, ++ –
6 ++, ++, ++, ++ ++, +, –, – ++, ++, +, + –
7 +++, ++, ++, ++ +++, ++, +++, ++ +++, ++, +++, ++ –
8 +++, ++, ++, ++ +++, ++, ++, ++ +++, ++, ++, ++ –
9 ++, ++, ++, ++ ++, ++, ++, + +++, ++, ++, ++ –
AD patients
1 ++, +, +, + ++, +, +, + ++, +, ++,+ –
2 +, –, –, – +, –, –, – ++, +, –, + –
Staining intensity: – = No immunoreactivity; + = slight; ++ = moderate; +++ = high; GC = ganglion cells 
including nerve ﬁ ber layer; AC = amacrine cells; PC = photoreceptor cells ; IOPL = inner and outer plexiform 
layers.
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intensity for all observed antigens ( table 2 ). In contrast to 
the control cases, overall OX-R1 immunoreactivity was 
weak in both AD cases with decreased orexin A or orex-
in B staining. 
 Discussion 
 The present results provide the ﬁ rst immunohisto-
chemical description of orexin A, orexin B and OX-R1 
distribution in human retina. Neuronal retinal cells and 
their cellular processes were the main localization sites, 
Fig. 1. Orexin-A-, orexin-B- and OX-R1-immunoreactive structures (red deposits) in the retina. GCL  { Ganglion 
cell layer; IPL  { inner plexiform layer; INL  { inner nuclear layer; OPL  { outer plexiform layer; ONL  { outer 
nuclear layer. Ganglion cells in the GCL, amacrine cells (asterisks) in the INL, and cell processes in the IPL and 
OPL are immunoreactive for orexin A ( A ), orexin B ( B ) and OX-R1 in controls ( C ).  D OX-R2 immunoreactivity 
is missing in a simultaneously stained section.  E Control section stained simultaneously according to the same 
procedure, with the exception that the primary antibody was omitted. The lack of immunoreactivity conﬁ rms the 
speciﬁ city of the reaction.  F The overall intensity of orexin A immunoreactivity is decreased in the retina of an 
AD patient.  A–F Original magniﬁ cation  ! 242. 
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These cells are also susceptible to the regulatory action of 
an important circadian modulatory hormone, melatonin 
 [24, 31] . Dopaminergic and GABAergic output of the am-
acrine cells is directly regulated by melatonin  [31] . Since 
orexin-A- and orexin-B-positive ﬁ bers  [9] and OX-R1 ex-
pression  [16] have been localized in the SCN, orexins may 
be involved in the retinohypothalamic tract from the ama-
crine and ganglion cells projecting to the SCN. Indeed, the 
distribution of orexin ﬁ bers and the orexin-induced c-fos 
expression in the SCN suggest that orexins may activate 
many neurons of the circadian pacemaker directly  [9] and 
thus be involved in circadian regulation  [17] . 
 The present data on 2 AD cases are too preliminary 
to allow disease-speciﬁ c interpretations. However, the 
reduced overall intensity of all observed antigens is of 
interest. AD pathology is complex, involving different 
neurotransmitter systems and resulting in cognitive, cir-
cadian and behavioral disturbances  [26] , as well as eating 
disorders  [32] , which partly overlap with orexin-related 
effects. Orexins may contribute via entrainment path-
ways, sleep and feeding behavior to AD pathology and 
clinical symptomatology. 
with ganglion and amacrine cells being most prominent. 
OX-R2 immunoreactivity was entirely absent. OX-R1 
may be the main receptor transducing the effects of both 
orexin A and orexin B in the retina. An alternative ex-
planation for the absence of OX-R2 immunoreactivity 
may be that the subjects were elderly, since brain OX-R2 
mRNA levels show an age-related decline  [28] . 
 Certain retinal ganglion cells appear to be intrinsically 
photosensitive  [29] and transmit photic information to 
the SCN, the site of the master circadian clock, via a direct 
retinohypothalamic tract  [22, 23] . Therefore, these cells 
play an important role in light entrainment of circadian 
rhythms. Our data mark ganglion and amacrine cells as 
the main localization site of orexin A, orexin B and OX-
R1 suggesting a role for orexins as regulatory peptides for 
the retinohypothalamic tract. 
 In rats, orexin A has been found to modulate the sleep-
wake cycle  [30] . Intracerebroventricularly administered 
orexin A enhanced arousal. This effect can be traced back 
to the dense innervation of orexinergic nerves in the locus 
ceruleus  [30] . In the retina, orexins may act on ganglion 
and amacrine cells as participants of the circadian system. 
Fig. 2.  Orexin-A- ( A ) and OX-R1- ( B ) immunoreactive structures in outer layers of the retina including the posi-
tively stained inner segments (IS) of the photoreceptor cells adjacent to the outer nuclear layer (ONL).  C ,  D Con-
trol sections.  A–D Original magniﬁ cation  ! 242.
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